Peptide Peppers' GHK-Cu + TB-500 + Ipamorelin Skin/Hair Stack
Three peptides and one stack that rebuilds skin, collagen, and hair from the inside out. GHK-Cu is a copper peptide. Your body produces it naturally but output drops sharply after your 20s. It binds directly to hair follicles, stimulates collagen and elastin production, and activates skin repair mechanisms that go dormant with age. Topical application daily. Injectable 1–2 mg two to three times per week. TB-500 is a fragment of Thymosin Beta-4. A protein your body already uses for tissue repair and cell regeneration. It reactivates the hair follicle growth cycle, reduces inflammation, and accelerates structural tissue repair at the cellular level. 2–2.5 mg twice per week. Ipamorelin triggers a clean growth hormone pulse before sleep. No cortisol. No prolactin. Just GH. GH is the primary driver of collagen synthesis and skin renewal. It peaks naturally during sleep. Ipamorelin amplifies that window. 200–300 mcg pre-sleep. Three different mechanisms. Follicle activation. Tissue repair. Hormonal output. Running all three together is proved to have high efficiency.
A reasonable cosmetic peptide trio with sane doses, undermined by vendor-grade overclaims. GHK-Cu and ipamorelin have real mechanisms for skin and the GH pulse. TB-500's hair regrowth claim is animal-data only — there's no human trial showing it grows hair — and 'proved to have high efficiency' for the three-compound combo isn't backed by anything published.
| Goal | Score | Grade | Weight | Why |
|---|---|---|---|---|
| Longevity | 70 | C- | 80% | Cosmetic aging markers (skin, collagen, hair) via three real mechanisms at community-standard doses. The hair regrowth claim from TB-500 isn't human-evidenced and the 'proven combo efficiency' claim isn't backed by anything published. |
| Cognition | — | Not targeted | — | Not targeted: no nootropic in the stack. |
| Sleep & recovery | 72 | C- | 20% | Pre-sleep ipamorelin can deepen the natural overnight GH pulse and TB-500 has a tissue-repair footprint. Recovery isn't the headline goal but the timing makes sleep adjacency real. |
| Energy & metabolism | — | Not targeted | — | Not targeted: no metabolic intervention. |
| Body recomposition | — | Not targeted | — | Not targeted: no anabolic agent or training stimulus, and ipamorelin at 200–300 mcg is dosed for the GH/sleep pulse, not muscle accretion. |
Ingredients (3)
GHK-Cu
- Dose
- Topical daily; injectable 1–2 mg, 2–3x/week · Topical: any time. Injectable: not specified.
- Mechanism
- Copper-binding tripeptide that stimulates fibroblast collagen and elastin synthesis, modulates wound-healing gene expression, and acts as an antioxidant via copper redox chemistry. Endogenous plasma levels decline with age.
- Take
- Topical GHK-Cu daily and 1–2 mg injectable 2–3x/week is the standard community protocol and matches the in-vitro/animal dosing equivalents. The cosmetic skin evidence is overwhelmingly topical (multiple human RCTs for fine lines and skin firmness); systemic injectable for skin and hair is community practice, not clinically established. The post conflates the two evidence bases.
TB-500
- Dose
- 2–2.5 mg, 2x/week · Not specified
- Mechanism
- Synthetic fragment (LKKTETQ region) of Thymosin Beta-4, an actin-sequestering protein involved in cell migration and tissue repair. Animal models suggest accelerated wound healing and possible follicle activation.
- Take
- 2–2.5 mg twice weekly is the consensus dose for the soft-tissue-healing community use case, and is not unreasonable for that. The hair-cycle reactivation claim, however, comes from a single set of mouse studies on full-length TB4 — there is no human RCT showing TB-500 grows hair. Honest framing is 'tissue repair adjunct' not 'hair growth peptide.'
Ipamorelin
Ipamorelin on peptidelist.org ↗
- Dose
- 200–300 mcg pre-sleep · Before sleep
- Mechanism
- Selective ghrelin receptor (GHS-R) agonist that triggers a pulsatile GH release without measurable elevation of cortisol, prolactin, or ACTH at typical doses. Pre-sleep timing layers on the natural overnight GH pulse, which drives IGF-1-mediated collagen synthesis.
- Take
- 200–300 mcg pre-sleep is on the conservative end of the community range (some run 300 mcg 2–3x/day). Reasonable for amplifying the overnight pulse without obvious side-effect tradeoffs. The author's claim that ipamorelin 'amplifies' the sleep GH window is correct mechanistically; whether the resulting IGF-1 bump translates to visible skin/collagen change in monotherapy at this dose is the unknown.
Risks & interactions
- TB-500 hair regrowth claim is not human-evidencedmedium
The 'reactivates the hair follicle growth cycle' framing comes from a small number of mouse studies on full-length Thymosin Beta-4, not on the LKKTETQ fragment that is sold as TB-500. There is no published human RCT showing TB-500 grows hair. A reader looking for hair regrowth from this protocol is buying a mechanistic story, not a clinical outcome — topical minoxidil 5% and oral finasteride are the actual evidence-based hair interventions and they aren't on the list.
- Chronic GH-axis stimulation without IGF-1 monitoringmedium
Ipamorelin elevates GH and downstream IGF-1. Sustained IGF-1 elevation is associated in observational and mechanistic literature with mTOR-driven proliferation pathways and is a plausible cancer-progression concern at supraphysiologic levels. Running pre-sleep ipamorelin chronically with no IGF-1 labs leaves the one cleanly trackable safety parameter unmonitored.
- Vendor-marketing voice and provenancemedium
Phrasing like 'proved to have high efficiency' is marketing copy, not clinical language. The handle 'Peptide Peppers' is consistent with a reseller, and reseller stack posts often reflect inventory more than optimization. Research-vendor peptide quality varies widely (HPLC purity, endotoxin, peptide content); buyers should expect to verify COAs themselves rather than trust the source.
- Topical vs injectable GHK-Cu evidence are conflatedlow
Topical GHK-Cu has the actual cosmetic skin RCTs (fine lines, skin firmness, wound healing). Injectable systemic GHK-Cu for hair and skin is community practice with much thinner clinical support — pharmacokinetics and tissue partitioning are different routes. The post treats them as a single intervention; readers should understand which evidence supports which route.
TB-500 is the weakest evidence link in the stack and it carries the most-overclaimed outcome (hair regrowth). Dropping it leaves two compounds with real, well-characterized mechanisms — GHK-Cu for skin/collagen and ipamorelin for the overnight GH pulse — at meaningful cost savings, and removes the headline claim the literature can't back.
Estimated cost
Research-peptide-vendor pricing for the three injectables plus a topical GHK-Cu serum: GHK-Cu injectable ~$40–60 + topical $30–80, TB-500 ~$100–160, ipamorelin ~$45–70. Compounding pharmacy via a TRT/peptide clinic would be 2–3x higher. Sourcing risk applies.